Equities

Ontrak Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
HY11:MUN

Ontrak Inc

Actions
  • Price (EUR)2.85
  • Today's Change0.00 / 0.00%
  • Shares traded--
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 07:01 BST.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Ontrak, Inc. is a value-based behavioral healthcare company that identifies and engages people with unmet health needs using its advanced engagement system to improve clinical outcomes. The Company identifies, engages, and delivers care to the vulnerable members of the behavioral health population who would otherwise fall through the cracks of the healthcare system. Through its Advanced Engagement System, it engages individuals with anxiety, depression, substance use disorders and chronic disease by delivering personalized care coaching and customized care pathways that help them receive the treatment and advocacy they need, despite the socio-economic, medical and health system barriers that exacerbate the severity of their comorbid illnesses. It integrates AI, predictive analytics, comprehensive clinical and claims data, patient-generated information, and digital interfaces with care coach engagements to deliver improved member health and better healthcare system utilization.

  • Revenue in USD (TTM)10.18m
  • Net income in USD-81.45m
  • Incorporated2003
  • Employees104.00
  • Location
    Ontrak Inc333 S. E. 2ND AVENUE, SUITE 2000MIAMI 33131United StatesUSA
  • Phone+1 (310) 444-4300
  • Fax+1 (310) 444-5300
  • Websitehttps://ontrakhealth.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.